| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.55e-04 | 6 | 65 | 2 | GO:0015277 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.42e-04 | 6 | 65 | 2 | GO:0032983 | |
| Domain | ANF_lig-bd_rcpt | 3.01e-04 | 37 | 66 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.01e-04 | 37 | 66 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 3.52e-04 | 39 | 66 | 3 | IPR028082 | |
| Domain | AAA | 8.23e-04 | 52 | 66 | 3 | PF00004 | |
| Domain | ATPase_AAA_core | 9.19e-04 | 54 | 66 | 3 | IPR003959 | |
| Domain | Dynein_HC_stalk | 1.09e-03 | 14 | 66 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.09e-03 | 14 | 66 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.09e-03 | 14 | 66 | 2 | PF08393 | |
| Domain | MT | 1.09e-03 | 14 | 66 | 2 | PF12777 | |
| Domain | DHC_fam | 1.25e-03 | 15 | 66 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.25e-03 | 15 | 66 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.25e-03 | 15 | 66 | 2 | PF03028 | |
| Domain | AAA+_ATPase | 1.69e-03 | 144 | 66 | 4 | IPR003593 | |
| Domain | AAA | 1.69e-03 | 144 | 66 | 4 | SM00382 | |
| Domain | Iontro_rcpt | 1.81e-03 | 18 | 66 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.81e-03 | 18 | 66 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 1.81e-03 | 18 | 66 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.81e-03 | 18 | 66 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.81e-03 | 18 | 66 | 2 | SM00918 | |
| Domain | Lig_chan | 1.81e-03 | 18 | 66 | 2 | PF00060 | |
| Domain | PBPe | 1.81e-03 | 18 | 66 | 2 | SM00079 | |
| Domain | - | 2.26e-03 | 663 | 66 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 3.33e-03 | 706 | 66 | 8 | IPR013783 | |
| Domain | Collagen | 3.39e-03 | 85 | 66 | 3 | IPR008160 | |
| Domain | Collagen | 3.39e-03 | 85 | 66 | 3 | PF01391 | |
| Domain | Ig_I-set | 4.58e-03 | 190 | 66 | 4 | IPR013098 | |
| Domain | I-set | 4.58e-03 | 190 | 66 | 4 | PF07679 | |
| Pubmed | 1.82e-06 | 46 | 66 | 4 | 30419336 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 24509855 | ||
| Pubmed | Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. | 3.55e-06 | 2 | 66 | 2 | 20026654 | |
| Pubmed | Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. | 3.55e-06 | 2 | 66 | 2 | 23462118 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 14695167 | ||
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 1.06e-05 | 3 | 66 | 2 | 27346345 | |
| Pubmed | Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. | 1.06e-05 | 3 | 66 | 2 | 18006705 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16427009 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 25676421 | ||
| Pubmed | Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung. | 1.06e-05 | 3 | 66 | 2 | 30673298 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 20421415 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30712845 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 28943310 | ||
| Pubmed | Loss of Roquin induces early death and immune deregulation but not autoimmunity. | 2.12e-05 | 4 | 66 | 2 | 21844204 | |
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 2.12e-05 | 4 | 66 | 2 | 12954862 | |
| Pubmed | Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program. | 2.12e-05 | 4 | 66 | 2 | 26728228 | |
| Pubmed | Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia. | 2.12e-05 | 4 | 66 | 2 | 28751718 | |
| Pubmed | DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. | 2.12e-05 | 4 | 66 | 2 | 12556884 | |
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 3.53e-05 | 5 | 66 | 2 | 23076118 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 15604234 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 28228252 | ||
| Pubmed | Transsynaptic Modulation of Kainate Receptor Functions by C1q-like Proteins. | 3.53e-05 | 5 | 66 | 2 | 27133466 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 3.53e-05 | 5 | 66 | 2 | 9593973 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 26448475 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 8288598 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 3.53e-05 | 5 | 66 | 2 | 18793656 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 29311308 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 12223554 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 18358623 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 3.53e-05 | 5 | 66 | 2 | 29058671 | |
| Pubmed | H2AFX and MDC1 promote maintenance of genomic integrity in male germ cells. | 3.53e-05 | 5 | 66 | 2 | 29437857 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.84e-05 | 208 | 66 | 5 | 33230847 | |
| Pubmed | MDC1 is required for the intra-S-phase DNA damage checkpoint. | 5.29e-05 | 6 | 66 | 2 | 12607003 | |
| Pubmed | RAG Represents a Widespread Threat to the Lymphocyte Genome. | 5.29e-05 | 6 | 66 | 2 | 26234156 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 26734725 | ||
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 5.29e-05 | 6 | 66 | 2 | 21734292 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 23230272 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 19450528 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 5.29e-05 | 6 | 66 | 2 | 28714086 | |
| Pubmed | Immune homeostasis and regulation of the interferon pathway require myeloid-derived Regnase-3. | 5.29e-05 | 6 | 66 | 2 | 31126966 | |
| Pubmed | Orientation-specific joining of AID-initiated DNA breaks promotes antibody class switching. | 7.40e-05 | 7 | 66 | 2 | 26308889 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 17428973 | ||
| Pubmed | Monoubiquitination of H2AX protein regulates DNA damage response signaling. | 7.40e-05 | 7 | 66 | 2 | 21676867 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 19342380 | ||
| Pubmed | BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. | 7.40e-05 | 7 | 66 | 2 | 16872911 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 14519663 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 19638463 | ||
| Pubmed | WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. | 9.86e-05 | 8 | 66 | 2 | 32518374 | |
| Pubmed | FIGNL1-containing protein complex is required for efficient homologous recombination repair. | 9.86e-05 | 8 | 66 | 2 | 23754376 | |
| Pubmed | A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. | 9.86e-05 | 8 | 66 | 2 | 19491398 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 26880763 | ||
| Pubmed | The histone demethylase LSD1/KDM1A promotes the DNA damage response. | 1.27e-04 | 9 | 66 | 2 | 24217620 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 20042577 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 34100982 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.27e-04 | 9 | 66 | 2 | 9051806 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.30e-04 | 135 | 66 | 4 | 28675934 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 27320916 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 20826529 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 24550317 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 22940690 | ||
| Pubmed | Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development. | 1.58e-04 | 10 | 66 | 2 | 15728677 | |
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 2446864 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.68e-04 | 430 | 66 | 6 | 35044719 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 12607005 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 20081839 | ||
| Pubmed | Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease. | 1.93e-04 | 11 | 66 | 2 | 31199454 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 29249358 | ||
| Pubmed | 2.10e-04 | 153 | 66 | 4 | 25037231 | ||
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 2.31e-04 | 12 | 66 | 2 | 18577246 | |
| Pubmed | Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells. | 2.39e-04 | 63 | 66 | 3 | 30762338 | |
| Pubmed | RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine. | 2.73e-04 | 13 | 66 | 2 | 27374884 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.73e-04 | 13 | 66 | 2 | 20859245 | |
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 20338046 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 30995416 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 26682986 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 27880911 | ||
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 15378723 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.28e-04 | 1201 | 66 | 9 | 35696571 | |
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 28002730 | ||
| Pubmed | Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. | 4.74e-04 | 17 | 66 | 2 | 22041458 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.49e-04 | 351 | 66 | 5 | 38297188 | |
| Pubmed | ILK modulates epithelial polarity and matrix formation in hair follicles. | 5.94e-04 | 19 | 66 | 2 | 24371086 | |
| Pubmed | 5.94e-04 | 19 | 66 | 2 | 34249474 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.97e-04 | 86 | 66 | 3 | 28327460 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.23e-04 | 361 | 66 | 5 | 26167880 | |
| Pubmed | 7.20e-04 | 212 | 66 | 4 | 19521566 | ||
| Pubmed | USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis. | 7.28e-04 | 21 | 66 | 2 | 32839293 | |
| Pubmed | E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. | 7.28e-04 | 21 | 66 | 2 | 15775979 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 8.31e-04 | 582 | 66 | 6 | 20467437 | |
| Pubmed | 8.75e-04 | 23 | 66 | 2 | 22912744 | ||
| Pubmed | Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. | 8.75e-04 | 23 | 66 | 2 | 18083014 | |
| Pubmed | IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. | 8.75e-04 | 23 | 66 | 2 | 29576451 | |
| Pubmed | 8.75e-04 | 23 | 66 | 2 | 33526661 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 9.53e-04 | 24 | 66 | 2 | 35746896 | |
| Pubmed | 1.03e-03 | 25 | 66 | 2 | 19180518 | ||
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 1.21e-03 | 27 | 66 | 2 | 17525332 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.27e-03 | 247 | 66 | 4 | 39238192 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.29e-03 | 248 | 66 | 4 | 24006456 | |
| Pubmed | 1.49e-03 | 30 | 66 | 2 | 31740976 | ||
| Pubmed | 1.49e-03 | 30 | 66 | 2 | 31043422 | ||
| Cytoband | 1p36.11 | 1.33e-04 | 68 | 66 | 3 | 1p36.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 4.45e-04 | 681 | 66 | 6 | chr1p36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 5.06e-04 | 107 | 66 | 3 | chr11q22 | |
| Cytoband | 1p13.1 | 1.04e-03 | 33 | 66 | 2 | 1p13.1 | |
| Cytoband | 11q22.3 | 1.85e-03 | 44 | 66 | 2 | 11q22.3 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 5.24e-05 | 5 | 42 | 2 | 1199 | |
| GeneFamily | AAA ATPases | 2.52e-04 | 53 | 42 | 3 | 413 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.21e-04 | 161 | 42 | 4 | 593 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.28e-03 | 42 | 42 | 2 | 602 | |
| GeneFamily | Collagens | 5.11e-03 | 46 | 42 | 2 | 490 | |
| GeneFamily | Immunoglobulin like domain containing | 1.01e-02 | 193 | 42 | 3 | 594 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 6.98e-07 | 199 | 66 | 7 | M4526 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 1.14e-05 | 200 | 66 | 6 | M8541 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | BOC COL6A1 COL9A2 THBS2 VPS13D SELENBP1 ZFHX4 GRIK4 C1orf216 BCL9 IL1R1 ITPKB | 1.91e-06 | 731 | 65 | 12 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | BOC COL6A1 COL9A2 VPS13D SELENBP1 ZFHX4 GRIK4 C1orf216 BCL9 IL1R1 ITPKB | 1.28e-05 | 734 | 65 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | BOC COL6A1 COL9A2 ZFHX4 GRIK4 C1orf216 OSGEP BCL9 IL1R1 ITPKB | 2.38e-05 | 642 | 65 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.92e-05 | 290 | 65 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | ESRP2 COL6A1 COL9A2 THBS2 SELENBP1 ZFHX4 C1QC LTBP1 GRIK4 C1orf216 IL1R1 CDH3 | 3.21e-05 | 967 | 65 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | ESRP2 ORC1 COL6A1 THBS2 GSPT2 ZFHX4 LRP11 PAK3 C1QC GRIK2 IL1R1 CDH3 | 3.52e-05 | 976 | 65 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | BOC COL6A1 COL9A2 THBS2 ZFHX4 GRIK4 C1orf216 OSGEP BCL9 IL1R1 ITPKB | 4.13e-05 | 834 | 65 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | BOC COL6A1 COL9A2 THBS2 ZFHX4 C1QC GRIK4 C1orf216 BCL9 IL1R1 ITPKB | 6.57e-05 | 878 | 65 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.60e-05 | 330 | 65 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | BOC COL6A1 COL9A2 THBS2 SELENBP1 ZFHX4 GRIK4 OSGEP BCL9 IL1R1 | 6.71e-05 | 726 | 65 | 10 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.52e-05 | 591 | 65 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BOC COL6A1 COL9A2 THBS2 ZFHX4 MDC1 GRIK4 C1orf216 BCL9 IL1R1 | 8.22e-05 | 744 | 65 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 1.25e-04 | 783 | 65 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | ESRP2 COL6A1 COL9A2 THBS2 ZFHX4 C1QC LTBP1 GRIK4 C1orf216 IL1R1 CDH3 | 1.55e-04 | 967 | 65 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.64e-04 | 655 | 65 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.01e-04 | 395 | 65 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.26e-04 | 567 | 65 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| ToppCell | (5)_Fibroblast-J_(Lipofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.63e-07 | 196 | 66 | 6 | afa29399decd17fda7d63add5039ff778627ccc2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.77e-07 | 197 | 66 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.06e-07 | 199 | 66 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.39e-06 | 170 | 66 | 5 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.39e-06 | 170 | 66 | 5 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 173 | 66 | 5 | 35dc897e06f905419d44093a92170d2cec35dd51 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 173 | 66 | 5 | 37825d0dda028cf677ff6ff16ea58bff75cb25a7 | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 180 | 66 | 5 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 185 | 66 | 5 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.12e-06 | 185 | 66 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 185 | 66 | 5 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.34e-06 | 186 | 66 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-06 | 186 | 66 | 5 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-06 | 186 | 66 | 5 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 187 | 66 | 5 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 188 | 66 | 5 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 8.78e-06 | 188 | 66 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-06 | 188 | 66 | 5 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-06 | 189 | 66 | 5 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 9.24e-06 | 190 | 66 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-06 | 190 | 66 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.24e-06 | 190 | 66 | 5 | 373629dde5eda722424c5e6087763f0c5db67cf4 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.48e-06 | 191 | 66 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.48e-06 | 191 | 66 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.48e-06 | 191 | 66 | 5 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.48e-06 | 191 | 66 | 5 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.72e-06 | 192 | 66 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 9.72e-06 | 192 | 66 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 9.97e-06 | 193 | 66 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.97e-06 | 193 | 66 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 66 | 5 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 195 | 66 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 198 | 66 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.13e-05 | 198 | 66 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.16e-05 | 199 | 66 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 199 | 66 | 5 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.16e-05 | 199 | 66 | 5 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 200 | 66 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.18e-05 | 200 | 66 | 5 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-05 | 200 | 66 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.18e-05 | 200 | 66 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 200 | 66 | 5 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-05 | 138 | 66 | 4 | 2709fb83dfe6c2e27050b08b678a6d6b25d47906 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 156 | 66 | 4 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 156 | 66 | 4 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.08e-04 | 166 | 66 | 4 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 166 | 66 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-ABC_aged-B_memory|blood / Manually curated celltypes from each tissue | 1.13e-04 | 168 | 66 | 4 | 2ce1a30feb2704a9516d1dab161a26cb0555abb5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 169 | 66 | 4 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 171 | 66 | 4 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 172 | 66 | 4 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 174 | 66 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-04 | 175 | 66 | 4 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 176 | 66 | 4 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 178 | 66 | 4 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 178 | 66 | 4 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 1.44e-04 | 179 | 66 | 4 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 1.44e-04 | 179 | 66 | 4 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 179 | 66 | 4 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 181 | 66 | 4 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 181 | 66 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 181 | 66 | 4 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 182 | 66 | 4 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 182 | 66 | 4 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 182 | 66 | 4 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 182 | 66 | 4 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 183 | 66 | 4 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.57e-04 | 183 | 66 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 183 | 66 | 4 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 183 | 66 | 4 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 185 | 66 | 4 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 185 | 66 | 4 | 239cc5184825b3cc98638d4aec0a1de8e508d76c | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.63e-04 | 185 | 66 | 4 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 185 | 66 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 185 | 66 | 4 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 186 | 66 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 187 | 66 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 187 | 66 | 4 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 187 | 66 | 4 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-04 | 187 | 66 | 4 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 66 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 188 | 66 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.74e-04 | 188 | 66 | 4 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 66 | 4 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.74e-04 | 188 | 66 | 4 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 189 | 66 | 4 | cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.77e-04 | 189 | 66 | 4 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 189 | 66 | 4 | 102501eee7760d5882dec41ea9d00147b3f4fb73 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.77e-04 | 189 | 66 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 189 | 66 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 189 | 66 | 4 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 66 | 4 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 189 | 66 | 4 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 66 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 189 | 66 | 4 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 66 | 4 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 66 | 4 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| Disease | Intervertebral disc disorder | 7.13e-05 | 6 | 65 | 2 | C0158252 | |
| Disease | myelofibrosis (implicated_via_orthology) | 7.13e-05 | 6 | 65 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | Psychotic Disorders | 7.46e-05 | 101 | 65 | 4 | C0033975 | |
| Disease | Congenital muscular dystrophy | 3.11e-04 | 12 | 65 | 2 | cv:C0699743 | |
| Disease | Inborn Errors of Metabolism | 6.36e-04 | 17 | 65 | 2 | C0025521 | |
| Disease | response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant | 6.36e-04 | 17 | 65 | 2 | EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276 | |
| Disease | exercise test | 8.85e-04 | 20 | 65 | 2 | EFO_0004328 | |
| Disease | Adenocarcinoma of large intestine | 1.26e-03 | 96 | 65 | 3 | C1319315 | |
| Disease | Agouti-related protein measurement | 1.62e-03 | 27 | 65 | 2 | EFO_0008016 | |
| Disease | congestive heart failure (is_implicated_in) | 1.62e-03 | 27 | 65 | 2 | DOID:6000 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTYKMELPGGTGCQP | 211 | Q9BYV1 | |
| YVVMCRTGGPGPKGI | 201 | Q9UKU7 | |
| VGEPGYCPVRLGMTT | 361 | Q9NPI1 | |
| KGQGVYLGMPGCLPV | 146 | P30040 | |
| PGAEPEKMGGAGTVC | 91 | Q8TAB5 | |
| SCPVYMGGPLGTAKL | 4706 | Q96M86 | |
| GPCAAGVVGIKMPRY | 926 | P25092 | |
| MAAPYPGSGGGSEVK | 1 | Q99742 | |
| GYGSPGQKGTVMGTL | 386 | Q14728 | |
| MKTPRCGVPDVGQYG | 86 | Q9H306 | |
| CPLGGTLDGVYPTLM | 1916 | Q9Y618 | |
| YGSQMCPGKLPEGIP | 96 | O75914 | |
| EQNGGMQCKPYGAGP | 351 | Q6PIW4 | |
| GPPGSGKTTYCLGMS | 16 | Q9H9Y4 | |
| QEDCPGPGSGGYSAM | 86 | Q86VZ4 | |
| PPQMGEIISCCGGTY | 2011 | Q14676 | |
| CGGPHTAVGTKYGMP | 86 | Q86YN1 | |
| PGMVCAGVPQGGKDS | 201 | Q9P0G3 | |
| SACAMGGPGTKSGEP | 506 | Q9NVR5 | |
| ETCTGAGYPQGKRMG | 91 | Q8IYD1 | |
| KEICPGGMGYTVSGV | 726 | Q14766 | |
| IGSTYGPPGGRKMTV | 2506 | Q96JB1 | |
| PGGQYMACVCPKGVP | 546 | Q3SXY7 | |
| MGKCKVYWEVGGPPG | 371 | Q92985 | |
| IDCIAYTKGPGMGAP | 71 | Q9NPF4 | |
| GNMLGTACGTPGYVA | 166 | Q6P2M8 | |
| MKGGGAIGPTQQGYP | 806 | Q96JP2 | |
| TGGCMYISGVPGTGK | 526 | Q13415 | |
| TVGYGDMCPTTPGGK | 421 | Q16322 | |
| GQANTGCYGIPGMPG | 26 | P02747 | |
| QVYPLLNCMEGIPGG | 76 | P15976 | |
| LNCMEGIPGGSPYAG | 81 | P15976 | |
| DSLYGCGGGKMLQPI | 2016 | Q13315 | |
| GAYVGQEPGMQLSPG | 1086 | Q9BWV1 | |
| DGVKGEMGYPGLPGC | 331 | P12109 | |
| MGGFYLCQPGPPSEK | 91 | P15391 | |
| NKIVGIGYNGMPNGC | 46 | P32321 | |
| GMIPGKDRGPAGLYT | 1356 | O00512 | |
| YKGMVGAIGATGPPG | 251 | Q14055 | |
| PSYGVCMEGSGKDSP | 401 | Q8N6P7 | |
| GGLIDSKGYGVGTPM | 756 | Q13002 | |
| GGLLDTKGYGIGMPV | 741 | Q16099 | |
| PPEVIQQYLSGGMCG | 76 | O76054 | |
| YGGTMTDPDGNPKCK | 241 | O76054 | |
| EGMGPPEIKYGESLC | 331 | P21817 | |
| KLPVAGDGGLVCPYM | 131 | P14778 | |
| EPGQALGKVFMGCPG | 46 | P22223 | |
| TCQVGMKPPVPGGYT | 306 | Q8N323 | |
| GVLNKGCGVGAPSPM | 571 | Q6ZVC0 | |
| KQIPPTVDGMLGGYG | 21 | Q9BV86 | |
| GQPVLIGGTMGTCSY | 396 | Q9Y3I0 | |
| GVLMYGPPGCGKTML | 201 | P43686 | |
| TGVKMLDTQGPPGCG | 406 | Q15572 | |
| YLPCGMPGSGEPEVG | 376 | P27987 | |
| GNCGPGYSTPLEAMK | 6 | Q13228 | |
| GGPGMYKVVKTGPSG | 2586 | O75592 | |
| LGGGPYMLCTDGQQL | 121 | Q9H6T0 | |
| GVTNPIMPGGYALAG | 456 | P51800 | |
| LTGFSGMKGUGCKVP | 51 | Q99611 | |
| GTVQGGYFPPVCGME | 3231 | Q86UP3 | |
| MGLPCVQTSGYQGGE | 486 | O15062 | |
| MPPGGGGPMKDCEYS | 1 | Q8IZN3 | |
| GDTICKGGEMPQGIY | 891 | Q5TAH2 | |
| MPGGGSQEYGVLCIQ | 1 | Q9C0D7 | |
| SPVPQMGGKNCKGSG | 466 | P35442 | |
| PEPGGGSGMLQYLQS | 421 | Q5THJ4 | |
| KLTDYGMCKEGLGPG | 391 | Q05513 | |
| MPPANGYIHKGTDGG | 881 | O94898 |